SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001400
Filing Date
2024-08-14
Accepted
2024-08-14 08:01:59
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcli-20240630x10q.htm   iXBRL 10-Q 1095479
2 EX-4.1 bcli-20240630xex4d1.htm EX-4.1 119775
3 EX-10.1 bcli-20240630xex10d1.htm EX-10.1 197966
4 EX-10.2 bcli-20240630xex10d2.htm EX-10.2 67246
5 EX-10.7 bcli-20240630xex10d7.htm EX-10.7 48110
6 EX-10.8 bcli-20240630xex10d8.htm EX-10.8 26532
7 EX-10.9 bcli-20240630xex10d9.htm EX-10.9 46429
8 EX-10.10 bcli-20240630xex10d10.htm EX-10.10 46266
9 EX-31.1 bcli-20240630xex31d1.htm EX-31.1 7845
10 EX-31.2 bcli-20240630xex31d2.htm EX-31.2 8465
11 EX-32.1 bcli-20240630xex32d1.htm EX-32.1 4997
12 EX-32.2 bcli-20240630xex32d2.htm EX-32.2 5028
  Complete submission text file 0001410578-24-001400.txt   4405752

Data Files

Seq Description Document Type Size
13 EX-101.SCH bcli-20240630.xsd EX-101.SCH 29668
14 EX-101.CAL bcli-20240630_cal.xml EX-101.CAL 27744
15 EX-101.DEF bcli-20240630_def.xml EX-101.DEF 97409
16 EX-101.LAB bcli-20240630_lab.xml EX-101.LAB 225125
17 EX-101.PRE bcli-20240630_pre.xml EX-101.PRE 182381
62 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20240630x10q_htm.xml XML 448310
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 241204259
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)